Company: SMNR
Filing Date: 2025-06-11
Form Type: S-4/A
Source: 0001193125-25-139124
Chunk: 334

Company: Semnur Pharmaceuticals, Inc.
Filing Date: 2025-06-11
Form: S-4/A
Chunk 334
---
 |     | OCI Holdings Company Ltd. (KOSE:A010060)                                                             |     |      216.1 |     |    153.2 |     |      7.6 |     |      3.6 |
| 11/08/21 |     | Katakura Industries Co., Ltd. (TSE:3001)        |     | —                                                                                                    |     |      418.1 |     |    332.4 |     |     52.0 |     |     26.5 |
| 09/01/21 |     | Swedish Orphan Biovitrum AB (publ) (OM:SOBI)    |     | Advent International, L.P.; GIC Special Investments Pte. Ltd.                                        |     |   10,536.8 |     |  1,686.1 |     |    659.3 |     |    435.3 |
| 08/25/21 |     | Hugel, Inc. (KOSDAQ:A145020)                    |     | IMM Investment, Corp.; GS Holdings Corp. (KOSE:A078930); CBC Group; Mubadala Investment Company PJSC |     |    1,906.7 |     |    221.0 |     |     87.9 |     |     77.2 |

Notes:

| (1) | Values in millions of US dollars. |

| (2) | Corresponding Enterprise Value multiples in tables below. |

| (3) | Source: S&P Capital IQ. |

191

| Date     |     | Target                                                             |     | Buyer / Investor                           |     | Enterprise 
   Value($) |     | Sales    
 (TTM)($) |     | EBITDA   
 (TTM)($) |     | EBIT     
 (TTM)($) |
| 07/23/24 |     | Aprogen Biologics Inc. (KOSE:A003060)                              |     | —                                          |     |      228.6 |     | 3.6x     |     | 8.3x     |     | 18.5x    |
| 07/08/24 |     | Grifols, S.A. (BME:GRF)                                            |     | Brookfield Capital Partners (Uk) Limited   |     |   18,663.8 |     | 2.6